We’re happy to announce that Practice Fusion’s certified e-prescribing for controlled substances (EPCS) feature will be available in Maine to help appropriately credentialed providers meet the state’s new EPCS mandate under L.D. 1646 by July 1, 2017.
L.D. 1646 Overview
Maine’s recently enacted law, L.D. 1646, An Act To Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program, requires that all prescribers register with Maine’s Prescription Monitoring Program (PMP) as of January 1, 2017. Under the Maine law, prescribers must also consult the PMP system prior to prescribing, or renewing a prescription for, an opioid or benzodiazepine medication.
Starting July 1, 2017, L.D. 1646 also requires all prescriptions for opioid medications to be sent electronically by prescribers. Additionally, prescribers must adhere to the opioid dosage limits set forth in L.D. 1646, which are outlined here.
In March 2017, the Maine Department of Health and Human Services adopted 14-118 C.M.R. Chapter 11, which contains emergency rules governing the Maine PMP and the prescribing of opioids. These rules include additional requirements for, and exemptions regarding, opioid prescriptions as well as dosage limitations. Under the rules, there are 8 possible exemptions to the 100 Morphine Milligram Equivalent aggregate daily limit for opioid prescriptions for which a prescription or patient may qualify. Prescribers must include an exemption code (Exemption Code A-H) on the prescription if they are claiming any of the exemptions from the opioid prescription dosage limitations under L.D. 1646. In the Practice Fusion EHR, these exemption codes and ICD-10 codes can be entered in the Note to Pharmacy field for applicable prescriptions.
Review the following resources for further information on the requirements of L.D. 1646: